With the goal of fighting the immense market of counterfeit products, several initiatives and legislative measures have been taken or are in the process of being implemented around the world, especially in the pharmaceutical industry.
USA: Drug Quality and Security Act (DQSA) as well as the Drug Supply Chain and Security Act, with an implementation milestone timeline set until 2023.
Turkey, India, Brazil, Australia, others: Various legislations are in place or in preparation.
On Falsified Medicine Directive 2011/62/EU please download the 'Product Traceability' whitepaper.
On general regulations (FDA, HACCP, GMP, etc.) please visit our regulations webpage (tcm:502-31119).